Opioid Induced Adrenal Insufficiency Complicated by Adrenal Crisis-A Case Report

William J Naber II
{"title":"Opioid Induced Adrenal Insufficiency Complicated by Adrenal Crisis-A Case Report","authors":"William J Naber II","doi":"10.37191/mapsci-jrpm-1(2)-011","DOIUrl":null,"url":null,"abstract":"Introduction: 1 in 5 people experience chronic pain that limits their ability to carry out activities of daily living. Opioid analgesics are one of the pharmaceutical interventions utilized to treat chronic pain. In fact, chronic pain is one of the most common reasons opioids are prescribed. Although many of the secondary effects of opioids are well known, a lesser-known side effect is opioid induced adrenal insufficiency (OIAI). OIAI can cause significant morbidity and has the potential to result in adrenal crisis, profound hypotension, and potential cardiovascular collapse, resulting in death. With sparse literature on OIAI, we present a case of OIAI complicated by adrenal crisis to expand awareness and discussion on the topic. Methods: The patient was a 65-year-old female on chronic opioid therapy for back pain who presented to the emergency room for syncope. On presentation, patient was hypotensive, bradycardic, and had an inadequate fluid response requiring pressors. Traditional etiologies of shock were ruled out, but interestingly morning cortisol and adrenocorticotropic hormone (ACTH) levels were low. Additionally, the cosyntropin stimulation test was suboptimal. Results suggested central hypothalamic pituitary axis suppression, which after discussion with Endocrinology indicated OIAI given the patient’s history. Results: Shortly after steroid regimen initiation the patient was weaned off pressors, and after multiple taper trials was successfully sent home on a steroid taper with Endocrinology follow up. Conclusion: Long term opioid use to treat chronic pain can decrease cortisol production via HPA axis suppression resulting in OIAI. To date, there is limited investigation into OIAI despite its increased prevalence and widespread use of opioids. The case adds to the available literature on OIAI, and sheds light on adrenal crisis as its initial presentation.","PeriodicalId":355292,"journal":{"name":"Journal of Rehabilitation and Pain Medicine","volume":"10 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rehabilitation and Pain Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37191/mapsci-jrpm-1(2)-011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: 1 in 5 people experience chronic pain that limits their ability to carry out activities of daily living. Opioid analgesics are one of the pharmaceutical interventions utilized to treat chronic pain. In fact, chronic pain is one of the most common reasons opioids are prescribed. Although many of the secondary effects of opioids are well known, a lesser-known side effect is opioid induced adrenal insufficiency (OIAI). OIAI can cause significant morbidity and has the potential to result in adrenal crisis, profound hypotension, and potential cardiovascular collapse, resulting in death. With sparse literature on OIAI, we present a case of OIAI complicated by adrenal crisis to expand awareness and discussion on the topic. Methods: The patient was a 65-year-old female on chronic opioid therapy for back pain who presented to the emergency room for syncope. On presentation, patient was hypotensive, bradycardic, and had an inadequate fluid response requiring pressors. Traditional etiologies of shock were ruled out, but interestingly morning cortisol and adrenocorticotropic hormone (ACTH) levels were low. Additionally, the cosyntropin stimulation test was suboptimal. Results suggested central hypothalamic pituitary axis suppression, which after discussion with Endocrinology indicated OIAI given the patient’s history. Results: Shortly after steroid regimen initiation the patient was weaned off pressors, and after multiple taper trials was successfully sent home on a steroid taper with Endocrinology follow up. Conclusion: Long term opioid use to treat chronic pain can decrease cortisol production via HPA axis suppression resulting in OIAI. To date, there is limited investigation into OIAI despite its increased prevalence and widespread use of opioids. The case adds to the available literature on OIAI, and sheds light on adrenal crisis as its initial presentation.
阿片类药物诱发肾上腺功能不全并发肾上腺危象--病例报告
简介每 5 人中就有 1 人因慢性疼痛而无法从事日常生活。阿片类镇痛药是治疗慢性疼痛的药物干预之一。事实上,慢性疼痛是处方阿片类药物的最常见原因之一。尽管阿片类药物的许多副作用已广为人知,但阿片类药物诱发肾上腺功能不全(OIAI)的副作用却鲜为人知。OIAI 可导致严重的发病率,并有可能导致肾上腺危象、深度低血压和潜在的心血管衰竭,从而导致死亡。由于有关 OIAI 的文献稀少,我们介绍了一例并发肾上腺危象的 OIAI 病例,以扩大对这一主题的认识和讨论。方法:患者是一名 65 岁的女性,因背部疼痛长期接受阿片类药物治疗,因晕厥到急诊室就诊。就诊时,患者血压低、心动过缓、液体反应不足,需要加压。传统的休克病因已被排除,但有趣的是,早晨皮质醇和促肾上腺皮质激素(ACTH)水平较低。此外,促肾上腺皮质激素刺激试验也不理想。结果显示下丘脑垂体轴中枢受抑制,与内分泌科讨论后,鉴于患者的病史,这表明患者患有 OIAI。结果:开始使用类固醇治疗后不久,患者就停用了加压素,经过多次减量试验后,患者在内分泌科的随访下成功减量类固醇并被送回家中。结论长期使用阿片类药物治疗慢性疼痛可通过抑制 HPA 轴减少皮质醇分泌,从而导致 OIAI。迄今为止,尽管阿片类药物的使用越来越普遍,但对 OIAI 的调查却十分有限。本病例补充了现有关于OIAI的文献,并揭示了肾上腺危象是其最初的表现形式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信